1296 related articles for article (PubMed ID: 10880551)
1. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers.
Mandelson MT; Oestreicher N; Porter PL; White D; Finder CA; Taplin SH; White E
J Natl Cancer Inst; 2000 Jul; 92(13):1081-7. PubMed ID: 10880551
[TBL] [Abstract][Full Text] [Related]
2. Biennial versus annual mammography and the risk of late-stage breast cancer.
White E; Miglioretti DL; Yankaskas BC; Geller BM; Rosenberg RD; Kerlikowske K; Saba L; Vacek PM; Carney PA; Buist DS; Oestreicher N; Barlow W; Ballard-Barbash R; Taplin SH
J Natl Cancer Inst; 2004 Dec; 96(24):1832-9. PubMed ID: 15601639
[TBL] [Abstract][Full Text] [Related]
3. Risk factors and tumor characteristics of interval cancers by mammographic density.
Holm J; Humphreys K; Li J; Ploner A; Cheddad A; Eriksson M; Törnberg S; Hall P; Czene K
J Clin Oncol; 2015 Mar; 33(9):1030-7. PubMed ID: 25646195
[TBL] [Abstract][Full Text] [Related]
4. Factors contributing to mammography failure in women aged 40-49 years.
Buist DS; Porter PL; Lehman C; Taplin SH; White E
J Natl Cancer Inst; 2004 Oct; 96(19):1432-40. PubMed ID: 15467032
[TBL] [Abstract][Full Text] [Related]
5. Mammographic changes resulting from benign breast surgery impair breast cancer detection at screening mammography.
van Breest Smallenburg V; Duijm LE; Voogd AC; Jansen FH; Louwman MW
Eur J Cancer; 2012 Sep; 48(14):2097-103. PubMed ID: 22513229
[TBL] [Abstract][Full Text] [Related]
6. Tumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening program.
Kirsh VA; Chiarelli AM; Edwards SA; O'Malley FP; Shumak RS; Yaffe MJ; Boyd NF
J Natl Cancer Inst; 2011 Jun; 103(12):942-50. PubMed ID: 21540443
[TBL] [Abstract][Full Text] [Related]
7. Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study.
Strand F; Humphreys K; Cheddad A; Törnberg S; Azavedo E; Shepherd J; Hall P; Czene K
Breast Cancer Res; 2016 Oct; 18(1):100. PubMed ID: 27716311
[TBL] [Abstract][Full Text] [Related]
8. Effect of false-positive mammograms on interval breast cancer screening in a health maintenance organization.
Burman ML; Taplin SH; Herta DF; Elmore JG
Ann Intern Med; 1999 Jul; 131(1):1-6. PubMed ID: 10391809
[TBL] [Abstract][Full Text] [Related]
9. Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers.
Porter PL; El-Bastawissi AY; Mandelson MT; Lin MG; Khalid N; Watney EA; Cousens L; White D; Taplin S; White E
J Natl Cancer Inst; 1999 Dec; 91(23):2020-8. PubMed ID: 10580027
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk.
Kerlikowske K; Ichikawa L; Miglioretti DL; Buist DS; Vacek PM; Smith-Bindman R; Yankaskas B; Carney PA; Ballard-Barbash R;
J Natl Cancer Inst; 2007 Mar; 99(5):386-95. PubMed ID: 17341730
[TBL] [Abstract][Full Text] [Related]
11. Frequency and predictive value of a mammographic recommendation for short-interval follow-up.
Yasmeen S; Romano PS; Pettinger M; Chlebowski RT; Robbins JA; Lane DS; Hendrix SL
J Natl Cancer Inst; 2003 Mar; 95(6):429-36. PubMed ID: 12644536
[TBL] [Abstract][Full Text] [Related]
12. Effect of mammographic breast density on breast cancer screening performance: a study in Nijmegen, The Netherlands.
van Gils CH; Otten JD; Verbeek AL; Hendriks JH; Holland R
J Epidemiol Community Health; 1998 Apr; 52(4):267-71. PubMed ID: 9616416
[TBL] [Abstract][Full Text] [Related]
13. Mammographic density and estrogen receptor status of breast cancer.
Ziv E; Tice J; Smith-Bindman R; Shepherd J; Cummings S; Kerlikowske K
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2090-5. PubMed ID: 15598766
[TBL] [Abstract][Full Text] [Related]
14. Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection.
Chiarelli AM; Kirsh VA; Klar NS; Shumak R; Jong R; Fishell E; Yaffe MJ; Boyd NF
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1856-62. PubMed ID: 17035392
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study.
Cuzick J; Warwick J; Pinney E; Duffy SW; Cawthorn S; Howell A; Forbes JF; Warren RM
J Natl Cancer Inst; 2011 May; 103(9):744-52. PubMed ID: 21483019
[TBL] [Abstract][Full Text] [Related]
16. Mammographic features associated with interval breast cancers in screening programs.
Boyd NF; Huszti E; Melnichouk O; Martin LJ; Hislop G; Chiarelli A; Yaffe MJ; Minkin S
Breast Cancer Res; 2014 Aug; 16(4):417. PubMed ID: 25346388
[TBL] [Abstract][Full Text] [Related]
17. Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography.
Laya MB; Larson EB; Taplin SH; White E
J Natl Cancer Inst; 1996 May; 88(10):643-9. PubMed ID: 8627640
[TBL] [Abstract][Full Text] [Related]
18. Invasive cancers detected after breast cancer screening yielded a negative result: relationship of mammographic density to tumor prognostic factors.
Roubidoux MA; Bailey JE; Wray LA; Helvie MA
Radiology; 2004 Jan; 230(1):42-8. PubMed ID: 14695385
[TBL] [Abstract][Full Text] [Related]
19. Mammographic density and estimation of breast cancer risk in intermediate risk population.
Tesic V; Kolaric B; Znaor A; Kuna SK; Brkljacic B
Breast J; 2013; 19(1):71-8. PubMed ID: 23173778
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]